BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16290980)

  • 1. Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril.
    Wagner M; Rindress D; Desjardins B; Meilleur MC; Ducharme A; Tardif JC
    Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
    Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
    Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E
    Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
    Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
    Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study.
    Fung JW; Sanderson JE; Yip GW; Zhang Q; Yu CM
    J Card Fail; 2007 Oct; 13(8):649-55. PubMed ID: 17923357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and heart failure.
    Larned JM; Raja Laskar S
    Congest Heart Fail; 2009; 15(1):24-30. PubMed ID: 19187404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
    Dagres N; Nieuwlaat R; Vardas PE; Andresen D; Lévy S; Cobbe S; Kremastinos DT; Breithardt G; Cokkinos DV; Crijns HJ
    J Am Coll Cardiol; 2007 Feb; 49(5):572-7. PubMed ID: 17276181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
    To AC; Yehia M; Collins JF
    Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation in 2010: an increasing morbidity and mortality burden].
    Davy JM; Roubille F; Tri Cung T; Massin F; Crausac F; Raczka F; Pasquié JL
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59 Suppl 1():S4-13. PubMed ID: 21211625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
    Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis.
    Ruigómez A; Johansson S; Wallander MA; Edvardsson N; García Rodríguez LA
    Int J Cardiol; 2009 Aug; 136(2):186-92. PubMed ID: 18625526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.